Publications

Chen DG, Xie J, Choi J, Ng RH, Zhang R, Li S, Edmark R, Zheng H, Solomon B, Campbell KM, Medina E, Ribas A, Khatri[...]

By sjmartinez • March 2, 2024

Altherr C, Sietsema KE, Fulkerson Z. When the Powerhouse Is the Problem. Ann Am Thorac Soc. 2024 Mar;21(3):504-511. doi: 10.1513/AnnalsATS.202308-715CC. PMID: 38426825.

By sjmartinez • March 2, 2024

Wu TC, Deng J, Chu FI, Sadeghi S, Finn R, Agopian VG, Lee P, Raldow AC. Single center experience using stereotactic body radiation therapy (SBRT)[...]

By sjmartinez • March 1, 2024

Badr MS, Martin JL, Sankari A, Zeineddine S, Salloum A, Henzel MK, Strohl K, Shamim-Uzzaman A, May AM, Fung CH, Pandya N, Carroll S, Mitchell[...]

By sjmartinez • March 1, 2024

Frutos AM, Price AM, Harker E, Reeves EL, Ahmad HM, Murugan V, Martin ET, House S, Saade EA, Zimmerman RK, Gaglani M, Wernli KJ, Walter[...]

By sjmartinez • March 1, 2024

Veena MS, Gahng JJ, Alani M, Ko AY, Basak SK, Liu IY, Hwang KJ, Chatoff JR, Venkatesan N, Morselli M, Yan W, Ali I, Kaczor-Urbanowicz[...]

By sjmartinez • March 1, 2024

Yano EM, Than C, Brunner J, Canelo IA, Meredith LS, Rubenstein LV, Hamilton AB. Impact of Evidence-Based Quality Improvement on Tailoring VA's Patient-Centered Medical Home[...]

By sjmartinez • March 1, 2024

Katoh M, Loriot Y, Brandi G, Tavolari S, Wainberg ZA, Katoh M. FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions. Nat Rev Clin[...]

By sjmartinez • March 1, 2024

Llovet JM, Pinyol R, Yarchoan M, Singal AG, Marron TU, Schwartz M, Pikarsky E, Kudo M, Finn RS. Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma.[...]

By sjmartinez • March 1, 2024